{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:09:37Z","timestamp":1788952177018,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570665"],"award-info":[{"award-number":["81570665"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["15XD1501000"],"award-info":[{"award-number":["15XD1501000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Commission of Health and Family Planning","award":["XBR2013080"],"award-info":[{"award-number":["XBR2013080"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jprot.2018.02.029","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T21:18:52Z","timestamp":1520543932000},"page":"42-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Comparative proteomic analysis of chief and oxyphil cell nodules in refractory uremic hyperparathyroidism by iTRAQ coupled LC-MS\/MS"],"prefix":"10.1016","volume":"179","author":[{"given":"Shensen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bihong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jprot.2018.02.029_bb0005","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.2215\/CJN.05910809","article-title":"Calcium metabolism in health and disease","volume":"5","author":"Peacock","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jprot.2018.02.029_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrneph.2010.17","article-title":"Recent advances in renal phosphate handling","volume":"6","author":"Farrow","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jprot.2018.02.029_bb0015","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jprot.2018.02.029_bb0020","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jprot.2018.02.029_bb0025","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jprot.2018.02.029_bb0030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2215\/CJN.06040614","article-title":"Comparison of fracture risk prediction among individuals with reduced and normal kidney function","volume":"10","author":"Naylor","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jprot.2018.02.029_bb0035","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jprot.2018.02.029_bb0040","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ki.1975.119","article-title":"Effect of 25-hydroxycholecalciferol on calcium absorption in chronic renal disease","volume":"8","author":"Rutherford","year":"1975","journal-title":"Kidney Int."},{"key":"10.1016\/j.jprot.2018.02.029_bb0045","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","article-title":"Parathyroid cell proliferation in normal and chronic renal failure rats. The effect of calcium, phosphate, and vitamin D","volume":"96","author":"Naveh-Many","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jprot.2018.02.029_bb0050","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jbmr.5650110714","article-title":"Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro","volume":"11","author":"Almad\u00e9n","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jprot.2018.02.029_bb0055","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jprot.2018.02.029_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","article-title":"Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease","volume":"90","author":"Carrillo-L\u00f3pez","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.jprot.2018.02.029_bb0065","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ndt\/gfu318","article-title":"Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice","volume":"30","author":"Arcidiacono","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jprot.2018.02.029_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD)","volume":"7","author":"Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","journal-title":"Kidney Int. Suppl."},{"issue":"3","key":"10.1016\/j.jprot.2018.02.029_bb0075","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ki.2014.425","article-title":"Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference","volume":"87","author":"Ketteler","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.jprot.2018.02.029_bb0080","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s11255-013-0637-2","article-title":"Calcitriol resistance in hemodialysis patients with secondary hyperparathyroidism","volume":"46","author":"Armando","year":"2014","journal-title":"Int. Urol. Nephrol."},{"issue":"Suppl. 5","key":"10.1016\/j.jprot.2018.02.029_bb0085","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1053\/ajkd.2001.28114","article-title":"Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism","volume":"38","author":"Llach","year":"2001","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.jprot.2018.02.029_bb0090","first-page":"176","article-title":"Safety and efficiency of treatment with cinacalcet of haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism","volume":"64","author":"Kuczera","year":"2013","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.jprot.2018.02.029_bb0095","series-title":"Endocrine Pathology: Differential Diagnosis and Molecular Advances","author":"Rub\u00e9n Harach","year":"2010"},{"key":"10.1016\/j.jprot.2018.02.029_bb0100","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2215\/CJN.04150907","article-title":"Does Vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of parathyroid glands in refractory uremic hyperparathyroidism?","volume":"3","author":"Lomonte","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jprot.2018.02.029_bb0105","first-page":"1","article-title":"Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride","volume":"12","author":"Sumida","year":"2011","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jprot.2018.02.029_bb0110","first-page":"716","article-title":"Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients","volume":"16","author":"Lomonte","year":"2003","journal-title":"J. Nephrol."},{"key":"10.1016\/j.jprot.2018.02.029_bb0115","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/modpathol.2010.132","article-title":"Parathyroid tumours and related disorders","volume":"24","author":"DeLellis","year":"2011","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.jprot.2018.02.029_bb0120","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3892\/ol.2016.4623","article-title":"Molecular pathways associated with transcriptional alterations in hyperparathyroidism","volume":"12","author":"Lee","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jprot.2018.02.029_bb0125","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00000478-198106000-00008","article-title":"Surgical pathology of hyperparathyroidism: usefulness of fat stain and problems in interpretation","volume":"5","author":"Kasdon","year":"1981","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.jprot.2018.02.029_bb0130","first-page":"116","article-title":"BB genotype of the vitamin D receptor gene polymorphism postpones parathyroidectomy in hemodialysis patients","volume":"16","author":"Borra's","year":"2003","journal-title":"J. Nephrol."},{"issue":"3","key":"10.1016\/j.jprot.2018.02.029_bb0135","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1523-1755.2005.00178.x","article-title":"Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients","volume":"67","author":"Kazama","year":"2005","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.jprot.2018.02.029_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1542-4758.2010.00514.x","article-title":"Switch from calcitriol to paricalcitol in secondary hyperparathyroidism of hemodialysis patients: responsiveness is related to parathyroid gland size","volume":"15","author":"Vulpio","year":"2011","journal-title":"Hemodial. Int."},{"issue":"4","key":"10.1016\/j.jprot.2018.02.029_bb0145","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1210\/jcem-63-4-954","article-title":"Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein","volume":"63","author":"Bikle","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jprot.2018.02.029_bb0150","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)80655-8","article-title":"An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3","volume":"96","author":"Nykjaer","year":"1999","journal-title":"Cell"},{"issue":"36","key":"10.1016\/j.jprot.2018.02.029_bb0155","doi-asserted-by":"crossref","first-page":"21760","DOI":"10.1016\/S0021-9258(20)88249-0","article-title":"The vitamin D-binding protein, alpha-fetoprotein, albumin multigene family: detection of transcripts in multiple tissues","volume":"264","author":"McLeod","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jprot.2018.02.029_bb0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/002215549704500306","article-title":"Tissue distribution of human gp330\/megalin, a putative Ca2+-sensing protein","volume":"45","author":"Lundgren","year":"1997","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.jprot.2018.02.029_bb0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-94-007-2888-2_5","article-title":"Signaling through the extracellular calcium-sensing receptor (CaSR)","volume":"740","author":"Chakravarti","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.jprot.2018.02.029_bb0170","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.kint.2017.05.003","article-title":"Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease","volume":"92","author":"Ritter","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.jprot.2018.02.029_bb0175","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1681\/ASN.2010060594","article-title":"Cyclooxygenase 2 promotes parathyroid hyperplasia in ESRD","volume":"22","author":"Zhang","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.jprot.2018.02.029_bb0180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF02893463","article-title":"Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism","volume":"10","author":"Szende","year":"2004","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.jprot.2018.02.029_bb0185","first-page":"2681","article-title":"Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism","volume":"82","author":"Satoshi","year":"1997","journal-title":"Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jprot.2018.02.029_bb0190","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1210\/jc.2004-1597","article-title":"Oxyphil parathyroid adenoma: a malignant presentation of a benign disease","volume":"89","author":"Fleischer","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jprot.2018.02.029_bb0195","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1146\/annurev.cellbio.20.010403.113126","article-title":"The Wnt signaling pathway in development and disease","volume":"20","author":"Logan","year":"2004","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.jprot.2018.02.029_bb0200","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nrm2717","article-title":"Proximal events in Wnt signal transduction","volume":"10","author":"Angers","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jprot.2018.02.029_bb0205","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","article-title":"\u03b2-catenin is a target for the ubiquitin\u2013proteasome pathway","volume":"16","author":"Aberle","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.jprot.2018.02.029_bb0210","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm3434","article-title":"TGF\u03b2 signalling in context","volume":"13","author":"Massague","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jprot.2018.02.029_bb0215","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2853","article-title":"TGF\u03b2 signalling: a complex web in cancer progression","volume":"10","author":"Ikushima","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jprot.2018.02.029_bb0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGF-\u03b2 in cancer","volume":"134","author":"Massague","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jprot.2018.02.029_bb0225","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.2619","article-title":"USP15 stabilizes TGF-\u03b2 receptor I and promotes oncogenesis through the activation of TGF-\u03b2 signaling in glioblastoma","volume":"18","author":"Eichhorn","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.jprot.2018.02.029_bb0230","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molcel.2013.07.014","article-title":"TRAF4 promotes TGF-\u03b2 receptor signaling and drives breast cancer metastasis","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jprot.2018.02.029_bb0235","doi-asserted-by":"crossref","first-page":"E91","DOI":"10.1038\/12087","article-title":"Kip1 meets SKP2: new links in cell-cycle control","author":"Amati","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jprot.2018.02.029_bb0240","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/onc.2013.144","article-title":"SCFs in the new millennium","volume":"33","author":"Lee","year":"2014","journal-title":"Oncogene"},{"issue":"36","key":"10.1016\/j.jprot.2018.02.029_bb0245","doi-asserted-by":"crossref","first-page":"58483","DOI":"10.18632\/oncotarget.11302","article-title":"DCUN1D3 activates SCFSKP2 ubiquitin E3 ligase activity and cell cycle progression under UV damage","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jprot.2018.02.029_bb0250","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1080\/15384101.2015.1044176","article-title":"MDM2 binds and inhibits vitamin D receptor","volume":"14","author":"Heyne","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jprot.2018.02.029_bb0255","doi-asserted-by":"crossref","first-page":"25260","DOI":"10.1074\/jbc.M311052200","article-title":"p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E\/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein\/Skp2 ubiquitin ligase","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.jprot.2018.02.029_bb0260","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.emboj.7601564","article-title":"Impaired DNA damage checkpoint response in MIF-deficient mice","volume":"26","author":"Nemajerova","year":"2007","journal-title":"EMBO J."}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391918300927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391918300927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T14:21:58Z","timestamp":1660573318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874391918300927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":52,"alternative-id":["S1874391918300927"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2018.02.029","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative proteomic analysis of chief and oxyphil cell nodules in refractory uremic hyperparathyroidism by iTRAQ coupled LC-MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jprot.2018.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}